loading
Schlusskurs vom Vortag:
$16.02
Offen:
$16.02
24-Stunden-Volumen:
110.21K
Relative Volume:
0.28
Marktkapitalisierung:
$302.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.20%
1M Leistung:
-8.90%
6M Leistung:
-0.11%
1J Leistung:
-48.53%
1-Tages-Spanne:
Value
$15.70
$16.67
1-Wochen-Bereich:
Value
$14.60
$18.03
52-Wochen-Spanne:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Firmenname
Tectonic Therapeutic Inc
Name
Telefon
(339) 666-3320
Name
Adresse
490 ARSENAL WAY, WATERTOWN
Name
Mitarbeiter
51
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
TECX's Discussions on Twitter

Vergleichen Sie TECX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TECX
Tectonic Therapeutic Inc
16.14 299.77M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.62 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.68 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
552.20 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.14 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.45 35.16B 4.56B -176.77M 225.30M -1.7177

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-03 Eingeleitet Oppenheimer Outperform
2025-07-21 Eingeleitet Truist Buy
2025-06-11 Fortgesetzt Raymond James Outperform
2025-04-21 Eingeleitet Mizuho Outperform
2024-11-20 Eingeleitet Raymond James Outperform
2024-08-22 Eingeleitet Wells Fargo Overweight
2024-06-26 Eingeleitet Piper Sandler Overweight
2024-06-24 Eingeleitet TD Cowen Buy
2023-12-18 Herabstufung Mizuho Buy → Neutral
2022-01-05 Herabstufung BTIG Research Buy → Neutral
2021-11-19 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-27 Eingeleitet Needham Buy
2021-03-09 Eingeleitet Barclays Overweight
2021-03-02 Eingeleitet Stifel Hold
2020-11-11 Eingeleitet Berenberg Buy
2020-03-31 Herabstufung H.C. Wainwright Buy → Neutral
2019-06-27 Eingeleitet Mizuho Buy
2019-04-05 Eingeleitet Janney Buy
2018-10-10 Eingeleitet Guggenheim Buy
2018-10-02 Bestätigt H.C. Wainwright Buy
2018-09-17 Eingeleitet H.C. Wainwright Buy
2018-07-16 Eingeleitet Wedbush Outperform
2018-07-16 Eingeleitet Wells Fargo Outperform
Alle ansehen

Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten

pulisher
04:38 AM

Can Tectonic Therapeutic Inc. stock deliver consistent earnings growthJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com

04:38 AM
pulisher
02:20 AM

Is it time to cut losses on Tectonic Therapeutic Inc.July 2025 Momentum & Entry and Exit Point Strategies - newser.com

02:20 AM
pulisher
Oct 12, 2025

Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock - Yahoo

Oct 12, 2025
pulisher
Oct 12, 2025

Will Tectonic Therapeutic Inc. benefit from macro trendsEarnings Summary Report & Reliable Intraday Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Has Tectonic Therapeutic Inc. found a price floorWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

News impact scoring models applied to Tectonic Therapeutic Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Key resistance and support levels for Tectonic Therapeutic Inc.July 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic (NASDAQ:TECX) Trading Up 3%Here's Why - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 3%Here's What Happened - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic’s (TECX) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic's (TECX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 06, 2025

Chart based exit strategy for Tectonic Therapeutic Inc.July 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Tectonic Therapeutic Inc. continue its uptrendInsider Buying & Technical Entry and Exit Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Tectonic Therapeutic Inc. stock entering bullish territoryTrade Entry Report & Safe Entry Trade Signal Reports - newser.com

Oct 05, 2025
pulisher
Sep 29, 2025

Tectonic Therapeutic stock soars on positive trial data - MSN

Sep 29, 2025
pulisher
Sep 28, 2025

Is Tectonic Therapeutic Inc a good long term investmentRisk Management Strategies & Build Winning Strategies With Zero Cost - Early Times

Sep 28, 2025
pulisher
Sep 27, 2025

What MACD and RSI say about Tectonic Therapeutic Inc.July 2025 Institutional & Momentum Based Trading Ideas - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

What drives Tectonic Therapeutic Inc stock pricePrice Support Zones & Turn Bull Runs into Life-Changing Wealth - Early Times

Sep 26, 2025
pulisher
Sep 26, 2025

Analyzing drawdowns of Tectonic Therapeutic Inc. with statistical toolsMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com

Sep 26, 2025
pulisher
Sep 25, 2025

Is Tectonic Therapeutic Inc. still worth holding after the dipEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 25, 2025
pulisher
Sep 24, 2025

Is a relief rally coming for Tectonic Therapeutic Inc. holders2025 Price Momentum & Weekly Setup with ROI Potential - newser.com

Sep 24, 2025
pulisher
Sep 22, 2025

Sector ETF performance correlation with Tectonic Therapeutic Inc.Exit Point & Smart Investment Allocation Insights - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Is Tectonic Therapeutic Inc. stock ready for a breakoutJuly 2025 Spike Watch & Weekly Top Performers Watchlists - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

CEO Moves: What are Tectonic Therapeutic Incs earnings expectationsJuly 2025 Review & Risk Managed Trade Strategies - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Will Tectonic Therapeutic Inc. stock recover after recent dropJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Targets Report: Will Tectonic Therapeutic Inc benefit from rate cutsJuly 2025 Retail & Fast Gain Stock Trading Tips - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Rate Cut: Is Tectonic Therapeutic Inc stock technically oversold2025 Historical Comparison & Weekly Watchlist of Top Performers - خودرو بانک

Sep 20, 2025

Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)

Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tectonic Therapeutic Inc-Aktie (TECX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
45,858
767,204
1,449,652
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
21,071
311,020
1,403,794
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
9,478
154,586
4,334,846
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
8,092
135,379
4,325,368
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
3,718
54,880
4,317,276
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
412,500
7,053,750
1,382,723
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
87,500
1,496,250
4,313,558
MCGUIRE TERRANCE
Director
Apr 07 '25
Sale
17.10
500,000
8,550,000
573,062
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
50.00
660,000
33,000,000
970,223
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
54.14
129,294
6,999,977
4,226,058
$84.69
price up icon 1.10%
$22.76
price up icon 6.16%
$32.50
price up icon 2.17%
$102.23
price up icon 0.32%
$166.15
price up icon 2.29%
biotechnology ONC
$331.45
price up icon 3.60%
Kapitalisierung:     |  Volumen (24h):